Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers

SLPI has been implicated in the progression and metastasis of certain cancers. However, the effects of SLPI seem to be tumor-specific and the mechanisms remain poorly defined. Here, we demonstrate that highly metastatic, triple-negative breast cancer (TNBC) 4T1 cells secreted more SLPI compared to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozin, Sergey V., Maimon, Nir, Wang, Rong, Gupta, Nisha, Munn, Lance, Jain, Rakesh K., Garkavtsev, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752445/
https://www.ncbi.nlm.nih.gov/pubmed/29312532
http://dx.doi.org/10.18632/oncotarget.22660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752445/
https://www.ncbi.nlm.nih.gov/pubmed/29312532
http://dx.doi.org/10.18632/oncotarget.22660

Ejemplares similares